Abstract:Aplastic anemia (AA) is a bone marrow failure syndrome mediated by hyperactivated T‐cells with heterogeneous pathogenic factors. A cellular atlas and microenvironment interactions is established using unbiased single‐cell RNA sequencing (scRNA‐seq) with the help of multi‐omics analysis (mass spectrometric analysis, cytokine profile, and oxidized fatty acids metabolome), and provide novel insights into the development of new therapeutic opportunities. Aplastic anemia (AA) is a bone marrow (BM) failure syndrome mediated by hyperactivated T‐cells with heterogeneous pathogenic factors. The onset of BM failure cannot be accurately determined in humans; therefore, exact pathogenesis remains unclear. In this study, a cellular atlas and microenvironment interactions is established using unbiased single‐cell RNA‐seq, along with multi‐omics analyses (mass cytometry, cytokine profiling, and oxidized fatty acid metabolomics). A new KIR+CD8+ regulatory T cells (Treg) subset is identified in patients with AA that engages in immune homeostasis. Conventional CD4+ T‐cells differentiate into highly differentiated T helper cells with type 2 cytokines (IL‐4, IL‐6, and IL‐13), GM‐SCF, and IL‐1β. Immunosuppressive homeostasis is impaired by enhanced apoptosis of activated Treg cells. Pathological Vδ1 cells dominated the main fraction of γδ T‐cells. The B/plasma, erythroid, and myeloid lineages also exhibit substantial pathological features. Interactions between TNFSF12‐TNFRSF12A, TNF‐TNFRSF1A, and granzyme‐gasdermin are associated with the cell death of hematopoietic stem/progenitor (HSPCs), Treg, and early erythroid cells. Ferroptosis, a major driver of HSPCs destruction, is identified in patients with AA. Furthermore, a case of twins with AA is reported to enhance the persuasiveness of the analysis. These results collectively constitute the cellular atlas and microenvironment interactions in patients with AA and provide novel insights into the development of new therapeutic opportunities.

Expression of IL-27, Th1 and Th17 in Patients with Aplastic Anemia.

Anti-inflammatory effects of interleukin-35 in acquired aplastic anemia

Dysregulated T-cell homeostasis and decreased CD30+ Treg proliferating in aplastic anemia

Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study

Decreased expression of vitamin D receptor may contribute to the hyperimmune status of patients with acquired aplastic anemia

Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemia

Role of miRNAs in T‐cell activation and Th17/Treg‐cell imbalance in acquired aplastic anemia

Reduced Regulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Activated T Lymphocytes and Th1/Th2 Cytokine Secretion in Children with Aplastic Anemia.

IL-11 promotes the treatment efficacy of hematopoietic stem cell transplant therapy in aplastic anemia model mice through a NF-κB/microRNA-204/thrombopoietin regulatory axis

[Clinical Significance of Serum Thrombopoietin Levels in Patients with Aplastic Anaemia].

Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia.

A study on T - cell subgroup in peripheral blood of children with aplastic anemia

Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia

Aberrant baseline cytokine profile in patients with newly diagnosed acquired aplastic anaemia correlates with disease severity and the treatment response

Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia

Unveiling immunological signatures and predictors of response to immunosuppressive therapy in acquired aplastic anemia

Effectiveness of Immunosuppressive Therapy for Childhood Aplastic Anemia and Its Predictive Factors

Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood: identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production

Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1α/RORγt pathway

Unbiased Single‐Cell Sequencing of Hematopoietic and Immune Cells from Aplastic Anemia Reveals the Contributors of Hematopoiesis Failure and Dysfunctional Immune Regulation

The role of TIM3 + NK and TIM3 - NK cells in the immune pathogenesis of severe aplastic anemia